PharmEste's Series B Round

PharmEste raised a round of funding on September 01, 2008.

PharmEste is a private biopharmaceutical company focused on the discovery and development of Transient Receptor Potential (TRP) channel therapeutics for the treatment of neuropathic pain, and other TR…

Articles about PharmEste's Series B Round: